Clinical Trial Update: Trial to Evaluate Safety, Tolerability, Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PerioSept® as an adjunct to scaling and root planing in periodontitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• PerioSept

Snippet

Sponsor: Geistlich Pharma AG | Conditions: Periodontitis | Phase 2 | Status: COMPLETED